Prime MedicinePRME
那斯達克 · USD
3.74
-0.10
(-2.48%)
收盤 03/13 03:59 (UTC+8)
03/13 03:59 (UTC+8)
Prime MedicinePRME
3.74
-0.10
(-2.48%)
財務數據
損益表
- -
- -
- 0.01
- -
- 0.00
- 0.02
- 0.01
- 0.01
- 0.01
- 0.01
- -
- -
- -
- -
- -
- 944.50
- -33.39
- -23.31
- 9.87
- -31.59
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 838 | 1,225 | 1,115 | 1,454 | 2,183 | 209 | - | 591 | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 838 | 1,225 | 1,115 | 1,454 | 2,183 | 209 | - | - | - | - |
營業費用 | 49,446 | 55,198 | 54,492 | 53,846 | 46,405 | 54,441 | 55,672 | - | 68,043 | 51,459 |
研發費用 | 34,709 | 43,990 | 41,375 | 40,562 | 34,104 | 40,340 | 43,071 | 37,774 | 41,459 | 40,967 |
推銷及管理費用 | 14,737 | 11,208 | 13,117 | 13,284 | 12,301 | 14,101 | 12,601 | 11,158 | 26,584 | 10,492 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -48,608 | -53,973 | -53,377 | -52,392 | -44,222 | -54,232 | -55,672 | -48,341 | -68,043 | -51,459 |
其他收入及費用 | 2,529 | 3,391 | 786 | 502 | 1,946 | 1,714 | 211 | 2,714 | 2,400 | 643 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -46,079 | -50,582 | -52,591 | -51,890 | -42,276 | -52,518 | -55,461 | -45,627 | -65,643 | -50,816 |
所得稅 | - | - | - | - | - | - | -134 | 134 | - | -108 |
稅後純益 | -46,079 | -50,582 | -52,591 | -51,890 | -42,276 | -52,518 | -55,327 | -45,761 | -65,643 | -50,708 |
基本每股稅後盈餘(元) | -0.30 | -0.32 | -0.41 | -0.40 | -0.31 | -0.44 | -0.46 | -0.44 | - | -0.55 |
稀釋每股稅後盈餘(元) | -0.24 | -0.32 | -0.41 | -0.40 | -0.31 | -0.44 | -0.46 | -0.44 | -0.72 | -0.55 |
基本平均股數(千股) | 144843.00 | 160503.00 | 129185.00 | 130884.00 | 130983.00 | 119764.00 | 119188.00 | 104466.00 | - | 91846.00 |
稀釋平均股數(千股) | 144843.00 | 160503.00 | 129185.00 | 130884.00 | 130983.00 | 119764.00 | 119188.00 | 104466.00 | - | 91846.00 |
還原基本每股稅後盈餘(元) | -0.30 | -0.32 | -0.41 | -0.40 | -0.31 | -0.44 | -0.46 | -0.44 | - | -0.55 |
還原稀釋每股稅後盈餘(元) | -0.24 | -0.32 | -0.41 | -0.40 | -0.31 | -0.44 | -0.46 | -0.44 | -0.72 | -0.55 |
還原基本平均股數(千股) | 144,843 | 160,503 | 129,185 | 130,884 | 130,983 | 119,764 | 119,188 | 104,466 | - | 91,846 |
還原稀釋平均股數(千股) | 144,843 | 160,503 | 129,185 | 130,884 | 130,983 | 119,764 | 119,188 | 104,466 | - | 91,846 |
EBITDA(千元) | -44,991 | -49,275 | -51,138 | -50,354 | -40,704 | -51,830 | -55,327 | -44,987 | -65,484 | -50,497 |